Physician profile
Janet E Erickson
NPI 1760461149
$1,468.77
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $325 · 2021: $138 · 2022: $121 · 2023: $56.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $218.85 | 2019-2023 | Wegovy |
| Pfizer INC. | $214.44 | 2019-2020 | |
| Lilly USA, LLC | $178.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $87.29 | 2019-2020 | |
| Amgen INC. | $82.27 | 2019-2021 | |
| Amarin Pharma, INC. | $79.14 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.39 | 2019-2021 | |
| Abbvie INC. | $61.45 | 2019-2021 | |
| Glaxosmithkline, LLC. | $53.23 | 2019 | |
| Abbott Laboratories | $52.54 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.73 | 2019-2023 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $36.38 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.00 | 2019 | |
| Sanofi Pasteur INC. | $30.87 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $26.84 | 2021 | |
| Allergan, INC. | $21.40 | 2019 | |
| Endo Pharmaceuticals INC. | $16.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.64 | 2020 | |
| Astellas Pharma US INC | $14.45 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.34 | 2019 | |
| Exact Sciences Corporation | $13.97 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.